Log in
Enquire now
‌

US Patent 11236111 Hepatitis B antiviral agents

Patent 11236111 was granted and assigned to Enanta Pharmaceuticals on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Current Assignee
Enanta Pharmaceuticals
Enanta Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112361110
Patent Inventor Names
Yat Sun Or0
Xiaowen Peng0
Xuri Gao0
Yao-Ling Qiu0
Byung-Chul Suh0
Hui Cao0
Jiajun Zhang0
Jorden Kass0
...
Date of Patent
February 1, 2022
0
Patent Application Number
168914010
Date Filed
June 3, 2020
0
Patent Citations
‌
US Patent 10428070 Hepatitis B antiviral agents
‌
US Patent 10179131 Hepatitis B antiviral agents
‌
US Patent 10179792 Hepatitis B antiviral agents
‌
US Patent 10189846 Hepatitis B antiviral agents
‌
US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound
0
‌
US Patent 10538532 Hepatitis B antiviral agents
Patent Primary Examiner
‌
Laura L. Stockton
0
Patent abstract

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11236111 Hepatitis B antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.